Mild ovarian stimulation for in vitro fertilization: One perspective from the USA

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 2, 2013, Pages 197-202

  Baker, Valerie L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Assisted reproductive technology; In vitro fertilization; Mild ovarian stimulation

Indexed keywords

CLOMIFENE; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HEALTH CARE COST; HORMONAL THERAPY; HUMAN; LIVE BIRTH; LOW BIRTH WEIGHT; OOCYTE; OOCYTE DONATION; OOCYTE RETRIEVAL; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY STIMULATION; PARTHENOGENESIS; PATIENT PREFERENCE; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTIVE PROCEDURE; REVIEW; UNITED STATES;

COST-BENEFIT ANALYSIS; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; UNITED STATES;

EID: 84878369470     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-9946-8     Document Type: Review

References (33)

1. Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman R, et al. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod. 2007;22:2801-4.
2. Zarek SM, Muasher SJ. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited. Fertil Steril. 2011;95:2449-55.
3. Siristatidis C, Trivella M, Chrelias C, Sioulas VD, Vrachnis N, Kassanos D. A short narrative review of the feasibility of adopting mild ovarian stimulation for IVF as the current standard of care. Arch Gynecol Obstet. 2012;286:505-10.
4. Verberg MF, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, et al. Mild ovarian stimulation for IVF. Hum Reprod Update. 2009;15:13-29.
5. Ubaldi F, Rienzi L, Ferrero S, Baroni E, Iacobelli M, Sapienza F, et al. Natural in vitro fertilization cycles. Ann N Y Acad Sci. 2004;1034:245-51. Review.
6. Fauser BC, Nargund G, Andersen AN, Norman R, Tarlatzis B, Boivin J, et al. Mild ovarian stimulation for IVF: 10 years later. Hum Reprod. 2010;25:2678-84.
7. Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007;369:743-9.
8. Verberg MF, Eijkemans MJ, Heijnen EM, Broekmans FJ, de Klerk C, Fauser BC, et al. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod. 2008;23:2050-5.
9. Blum J, Shochet T, Lynd K, Lichtenberg ES, Fischer D, Arnesen M, et al. Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study. Contraception. 2012;86:757-62.
10. Weinerman R, Grifo J. Consequences of superovulation and ART procedures. Semin Reprod Med. 2012;30:77-83.
11. Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab. 2004;15:84-90.
12. Santos MA, Kuijk EW, Macklon NS. The impact of ovarian stimulation for IVF on the developing embryo. Reproduction. 2010;139:23-34.
13. McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A, et al. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol. 2009;146:138-48.
14. Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a national institute of child health and human development workshop. Obstet Gynecol. 2007;109:967-77.
15. Conrad KP, Baker VL. Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies. Am J Physiol Regul Integr Comp Physiol. 2012
16. Luke B, Brown MB, Morbeck DE, Hudson SB, Coddington 3rd CC, Stern JE. Factors associated with Ovarian Hyperstimulation Syndrome (OHSS) and its effect on Assisted Reproductive Technology (ART) treatment and outcome. Fertil Steril. 2010;94:1399-404.
17. Baker VL, Brown MB, Luke B, Conrad KP. Association between multiple corpora lutea and birthweight among singletons from in vitro fertilization: analysis using Society for Assisted Reproductive Technology Clinical Outcome Reporting System. Fertil Steril. 2012;98:S16.
18. Bosch E, Ezcurra D. Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol. 2011;9:1-9.
19. Kato K, Takehara Y, Segawa T, Kawachiya S, Okuno T, Kobayashi T, et al. Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort. Reprod Biol Endocrinol. 2012;10:35.
20. Diedrich K, Fauser BC, Devroey P. Evian Annual Reproduction (EVAR) workshop group 2009. Cancer and fertility: strategies to preserve fertility. Reprod Biomed Online. 2011;22:232-48.
21. Teramoto S, Kato O. Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study. Reprod Biomed Online. 2007;15:134-48.
22. National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. 2009 Assisted reproductive technology; success rates national summary and fertility clinic reports. Centers for disease control and prevention. 2011 http://www.cdc.gov/art/ART2009/PDF/ART-2009-Full.pdf
23. Baker VL, Jones CE, Cometti B, Hoehler F, Salle B, Urbancsek J, et al. Factors affecting success rates in two concurrent clinical IVF trials: an examination of potential explanations for the difference in pregnancy rates between the United States and Europe. Fertil Steril. 2010;94:1287-91.
24. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Baart EB, Hohmann FP, et al. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum Reprod Update. 2009;15:5-12.
25. Luke B, Brown MB, Wantman E, Lederman A, Gibbons W, Schattman GL, et al. Cumulative birth rates with linked assisted reproductive technology cycles. N Engl J Med. 2012;366:2483-91.
26. Stern JE, Hickman TN, Kinzer D, Penzias AS, Ball GD, Gibbons WE. Can the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) be used to accurately report clinic total reproductive potential (TRP)? Fertil Steril. 2012;97:886-9.
27. Mansour R, Aboulghar M, Serour GI, Al-Inany HG, Fahmy I, Amin Y. The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol. Acta Obstet Gynecol Scand. 2003;82:48-52.
28. Baker VL, Gvakharia MO, Rone HM, Manalad JR, Adamson GD. Economic cost for implementation of the U.S. food and drug administration's code of federal regulations title 21, Part 1271 in an egg donor program. Fertil Steril. 2008;90:537-45.
29. The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. Recommendations for gamete and embryo donation: a committee opinion. Fertil Steril. 2012. [Epub ahead of print]
30. Ginsburg ES, Baker VL, Racowsky C, Wantman E, Goldfarb J, Stern JE. Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a society for assisted reproductive technology writing group paper. Fertil Steril. 2011;96:865-8.
31. Society of Assisted Reproductive Technology Clinic Outcome Reporting System. 2010 Clinic summary report. https://www.sartcorsonline.com/rptCSR- PublicMultYear.aspx?ClinicPKID=0
32. Treff NR, Scott Jr RT. Methods for comprehensive chromosome screening of oocytes and embryos: capabilities, limitations, and evidence of validity. J Assist Reprod Genet. 2012;29:381-90.
33. Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, et al. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007;22:980-8.